Mutation of the p16/CDKN2 gene and loss of heterozygosity in malignant mucosal melanoma and adenoid cystic carcinoma of the head and neck

International Journal of Oncology

Volumn 31, Issue 5, 2007, Pages 1061-1067

  Suzuki, Norihisa ^a   Onda, Takeshi ^a,b   Yamamoto, Nobuharu ^a   Katakura, Akira ^a   Mizoe, Jun Etsu ^b   Takahiko, Shibahara ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Adenoid cystic carcinoma; Head and neck cancer; Loss of heterozygosity; Malignant mucosal melanoma; p16 CDKN2

Indexed keywords

ADENOID CYSTIC CARCINOMA; ARTICLE; GENETICS; HEAD AND NECK TUMOR; HETEROZYGOSITY LOSS; HUMAN; MELANOMA; MICROSATELLITE INSTABILITY; MUTATION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

CARCINOMA, ADENOID CYSTIC; GENES, P16; HEAD AND NECK NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MELANOMA; MICROSATELLITE INSTABILITY; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 38449110694     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Tsujii H, Morita S, Miyamoto T, Mizoe J, Kamada T, Kato H, Tsuji H, Yamada S, Yamamoto N and Murata K: Experiences of carbon ion radiotherapy at NIRS. In: Proceedings of 7th International Meeting on Progress in Radio-Oncology ICRO/OGRO 7. Kogelnik HD and Sedlmayer F (eds). Monduzzi Editore, Austria, pp393-405, 2002.
2. Kamada T, Tsujii H, Tsuji H, Yanagi T, Mizoe J, Miyamoto T, Kato H, Yamada S, Morita S, Yoshikawa K, Kandatsu S and Tateishi A: Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcoma. J Clin Oncol 20: 4466-4471, 2002.
3. Miyamoto T, Yamamoto N, Nishimura H, Koto M, Tsujii H, Mizoe J, Kamada T, Kato H, Yamada S, Morita S, Yoshikawa K, Kandatsu S and Fujisawa T: Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 66: 127-140, 2003.
4. Yamamoto N, Mizoe J, Numasawa H, Yokoe H, Uzawa K, Shibahara T, Tsujii H, Noma H and Tanzawa H: Allelic loss of chromosome 2 in human oral squamous cell carcinoma: correlation with lymph node metastasis. Oral Oncol 39: 64-68, 2003.
5. Nakanishi H, Wang XL, Imai FL, Kato J, Shiiba M, Miya T, Imai Y and Tanzawa H: Localization of a novel tumor suppressor gene loci on chromosome 9p21-22 in oral cancer. Anticancer Res 19: 29-34, 1999.
6. Yamashita Y, Miyakawa A, Mochida Y, Aisaki K, Yama M, Shiiba M, Watanabe T, Yokoe H, Uzawa K, Imai Y and Tanzawa H: Genetic aberration on chromosome 10 in human oral squamous cell carcinoma. Int J Oncol 20: 595-598, 2002.
7. Yamamoto N, Noma H and Shibahara T: Allelic imbalance on the long arm of chromosome 21 in human oral squamous cell carcinoma: relationship between allelic imbalances (LOH and MSI) and clinicopathologic features. Bull Tokyo Dental College 42: 211-223, 2001.
8. Tomlinson IP, Beck NE and Bodmer WF: Allele loss on chromosome 11q and microsatellite instability in malignant melanoma. Eur J Cancer 32A: 1797-1802, 1996.
9. Stallmach I, Zenklusen P, Komminoth P, Schmid S, Perren A, Roos M, Jianming Z, Heitz PU and Pfaltz M: Loss of heterozygosity at chromosome 6q23-25 correlates with clinical and histologic parameters in salivary gland adenoid cystic carcinoma. Virchows Arch 440: 77-84, 2002.
10. Cerilli LA, Swartzbaugh JR, Saadut R, Marshall CE, Rumpel CA, Moskaluk CA and Frierson HF Jr: Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas. Hum Pathol 30: 1242-1246, 1999.
11. Walker GJ, Palmer JM, Walters MK and Hayward NK: A genetic model of melanoma tumorigenesis based on allelic losses. Genes Chromosomes Cancer 12: 134-141, 1995.
12. Deichmann M, Mollenhauer J, Helmke B, Thome M, Hartschuh W, Poustka A and Naher H: Analysis of losses of heterozygosity of the candidate tumour suppressor gene DMBT1 in melanoma resection specimens. Oncology 63: 166-172, 2002.
13. El-Rifai W, Rutherford S, Knuutila S, Frierson HF Jr and Moskaluk CA: Novel DNA copy number losses in chromosome 12q12-q13 in adenoid cystic carcinoma. Neoplasia 3: 173-178, 2001.
14. Yamamoto Y, Wistuba II, Kishimoto Y, Virmani AK, Vuitch F, Albores-Saavedra J and Gazdar AF: DNA analysis at p53 locus in adenoid cystic carcinoma: comparison of molecular study and p53 immunostaining. Pathol Int 48: 273-280, 1998.
15. Puizina-Ivic N, Pokupcic N, Musani V, Komar A, Kubat M, Furac I, Karija-Vlahovic M and Krizanac S: Alterations in CDKN2A locus as potential indicator of melanoma predisposition in relatives of non-familial melanoma cases. Croat Med J 44: 418-424, 2003
16. Wasi PN, Cohen B, Luthra UK and Torloni H: International histological classification of tumours, histological typing of oral and oropharyngeal tumours, 4. WHO, Geneva, 1971.
17. Nakamoto D, Yamamoto N, Takagi R, Katakura A, Mizoe J and Shibahara T: Detection of tumor DNA in plasma using whole genome amplification. Bull Tokyo Dent Coll 47: 125-131, 2006.
18. Uzawa K, Suzuki H, Yokoe H, Tanzawa H and Sato K: Mutational state of p16/CDKN2 and VHL genes in squamous-cell carcinoma of the oral cavity. Int J Oncol 7: 895-899, 1995.
19. Onda T, Uzawa K, Endo Y, Bukawa H, Yokoe H, Shibahara T and Tanzawa H: Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma. Br J Cancer 94: 698-709, 2006.
20. Bogdan I, Xin H, Burg G and Boni R: Heterogeneity of allelic deletions within melanoma metastases. Melanoma Res 11: 349-354, 2002.
21. Yakushiji T, Noma H, Shibahara T, Arai K, Yamamoto N, Tanaka C, Uzawa K and Tanzawa H: Analysis of a role for p16/CDKN2 expression and methylation patterns in human oral squamous cell carcinoma. Bull Tokyo Dent Coll 42: 159-168, 2001.
22. Chang AE, Karnell LH and Menck HR: The National Cancer Data Base Report on cutaneous and noncutaneous melanoma. Cancer 83: 1664-1678, 1998.
23. Batsakis JD, Regezi JA, Solomon AR and Rice DH: The pathology of head and neck tumors - part 13: mucosal melanomas. Head Neck Surg 4: 404-412, 1982.
24. Shah JP, Huvos AG and Strog EW: Mucosal melanomas of the head and neck. Am J Surg 134: 531-535, 1977.
25. Seifert G and Sobin LH: Histological typing of salivary gland tumours. WHO International histological classification of tumours. 2nd edition. Springer-Verlag, Berlin, 1991.
26. Kawano S, Oobu K, Matsunaga K, Kawano E, Mitate E, Suzuki H, Kobayashi I, Kiyoshoma T and Nakamura S: A clinicostatistical study of 151 patients with salivary gland tumors. Jpn J Oral Maxillofac Surg 7: 393-400, 2006.
27. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE and Sidransky D: Rates of p16(MTS1) mutations in primary tumors with 9p loss. Science 265: 415-416, 1994.
28. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Tavtigian SV, Stockert E, Day RS III, Johnson BE and Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 246: 436-440, 1994.
29. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756, 1994.
30. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ and Kern SE: Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8: 27-32, 1994.
31. Lamperska K, Karezewska A, Kwiatkowska E and Mackiewicz A: Analysis of mutations in the p16/CDKN2A gene in sporadic and familial melanoma in the Polish population. Acta Biochim Pol 49: 369-376, 2002.
32. Maruya S, Kurotaki H, Shimoyama N, Kaimori M, Shinkawa H and Yagihashi S: Expression of p16 protein and hypermethylation status of its promoter gene in adenoid cystic carcinoma of the head and neck. J Otorhinolaryngol 65: 26-32, 2003.